Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view

被引:8
作者
Pinier, Cedric [1 ]
Gatault, Philippe [1 ,2 ]
Fauchier, Laurent [3 ]
Angoulvant, Denis [2 ,3 ]
Francois, Maud [1 ]
Barbet, Christelle [1 ]
Bailly, Elodie [1 ]
Noble, Johan [1 ]
Chevallier, Eloi [1 ]
Rabot, Nolwenn [1 ]
Buchler, Matthias [1 ,2 ]
Sautenet, Benedicte [1 ,4 ,5 ]
Halimi, Jean-Michel [1 ,2 ,5 ]
机构
[1] CHU Tours, Serv Nephrol Hypertens, Hop Bretonneau, Transplantat Renale, Tours, France
[2] Francois Rabelais Univ, EA4245, Tours, France
[3] CHU Tours, Serv Cardiol, Hop Trousseau, Tours, France
[4] Francois Rabelais Univ, U1246, INSERM, Tours, France
[5] FCRIN INI CRCT Cardiovasc & Renal Clin Trialists, Paris, France
关键词
cardiovascular events; diabetes mellitus; end-stage renal disease; epidemiology; heart failure; CARDIORENAL SYNDROME; LONG-TERM; PROGNOSIS; OUTCOMES; PROGRESSION; RETINOPATHY; ESRD;
D O I
10.1093/ckj/sfz028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Interconnections between major cardiovascular events (MCVE5) and renal events are recognized in diabetes, however, the specific impact of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS) on the risk of end-stage renal disease (ESRD) on top of established renal risk factors is unclear in type 2 diabetes mellitus. Methods. We conducted a retrospective study in 861 consecutive patients followed in a nephrology setting during the 2000-13 period. Results. The mean age was 70 +/- 10 years, 65.1% were men and the estimated glomerular filtration rate (eGFR) was 42.4 +/- 21.0 mL/min/1.73 m(2). During follow-up (median 59 months), 194 patients reached ESRD. A history of AF, HF or ACS was associated with an increased risk of reduced baseline eGFR. In turn, reduced baseline eGFR resulted in a greater risk of new MCVE (especially HF) during follow-up. Finally, all new MCVE5 were risk factors for subsequent acute kidney injury (AKI) {HF: hazard ratio [HR] 8.99 [95% confidence interval (CI) 7.06-11.4]; AF: HR 5.42 (3.91-7.52); ACS: HR 8.82 (6.24-12.5); all P < 0.0001) and ESRD [HF: HR 5.52 (95% CI 4.01-7.60), P < 0.0001; AF: HR 3.48 (2.30-5.21), P < 0.0001; ACS: HR 2.31 (1.43-3.73), P = 0.0006]. The AF- and HF-associated risks of ESRD were significant after adjustments on all renal risks of ESRD (gender, blood pressure, eGFR, albuminuria, renin-angiotensin blockers, retinopathy and AKI), but the association was less strong for ACS. Importantly, no association was noted between other major events such as stroke or infections and the risk of ESRD. Conclusions. Past and new cardiovascular events (more HF and AF than ACS) have a strong, independent impact on the development of ESRD above and beyond established risk factors in diabetes.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 32 条
  • [1] Classification and Diagnosis of Diabetes
    不详
    [J]. DIABETES CARE, 2015, 38 : S8 - S16
  • [2] Atrial Fibrillation and Risk of ESRD in Adults with CKD
    Bansal, Nisha
    Xie, Dawei
    Tao, Kelvin
    Chen, Jing
    Deo, Rajat
    Horwitz, Edward
    Hsu, Chi-yuan
    Kallem, Radha Krishna
    Keane, Martin G.
    Lora, Claudia M.
    Raj, Dominic
    Soliman, Elsayed Z.
    Strauss, Louise
    Wolf, Myles
    Go, Alan S.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (07): : 1189 - 1196
  • [3] Association between AKI and Long-Term Renal and Cardiovascular Outcomes in United States Veterans
    Chawla, Lakhmir S.
    Amdur, Richard L.
    Shaw, Andrew D.
    Faselis, Charles
    Palant, Carlos E.
    Kimmel, Paul L.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (03): : 448 - 456
  • [4] Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
    Colombo, Paolo C.
    Ganda, Anjali
    Lin, Jeffrey
    Onat, Duygu
    Harxhi, Ante
    Iyasere, Julia E.
    Uriel, Nir
    Cotter, Gad
    [J]. HEART FAILURE REVIEWS, 2012, 17 (02) : 177 - 190
  • [5] Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26
    Cusick, M
    Chew, EY
    Hoogwerf, B
    Agrón, E
    Wu, L
    Lindley, A
    Ferris, FL
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (03) : 1173 - 1179
  • [6] Worsening renal function and prognosis in heart failure: Systematic review and meta-analysis
    Damman, Kevin
    Navis, Gerjan
    Voors, Adriaan A.
    Asselbergs, Folkert W.
    Smilde, Tom D. J.
    Cleland, John G. F.
    Van Veldhuisen, Dirk J.
    Hillege, Hans L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2007, 13 (08) : 599 - 608
  • [7] CKD Progression and Mortality among Hispanics and Non-Hispanics
    Fischer, Michael J.
    Hsu, Jesse Y.
    Lora, Claudia M.
    Ricardo, Ana C.
    Anderson, Amanda H.
    Bazzano, Lydia
    Cuevas, Magdalena M.
    Hsu, Chi-yuan
    Kusek, John W.
    Renteria, Amada
    Ojo, Akinlolu O.
    Raj, Dominic S.
    Rosas, Sylvia E.
    Pan, Qiang
    Yaffe, Kristine
    Go, Alan S.
    Lash, James P.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3488 - 3497
  • [8] Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
    Forman, DE
    Butler, J
    Wang, YF
    Abraham, WT
    O'Connor, CM
    Gottlieb, SS
    Loh, E
    Massie, BM
    Rich, MW
    Stevenson, LW
    Young, JB
    Krumholz, HM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) : 61 - 67
  • [9] Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
    Gansevoort, Ron T.
    Matsushita, Kunihiro
    van der Velde, Marije
    Astor, Brad C.
    Woodward, Mark
    Levey, Andrew S.
    de Jong, Paul E.
    Coresh, Josef
    [J]. KIDNEY INTERNATIONAL, 2011, 80 (01) : 93 - 104
  • [10] Global estimates of diabetes prevalence for 2013 and projections for 2035
    Guariguata, L.
    Whiting, D. R.
    Hambleton, I.
    Beagley, J.
    Linnenkamp, U.
    Shaw, J. E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 137 - 149